Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambulatory Continuous Peripheral Nerve Blocks for Phantom Limb Pain
NCT01824082Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Dec 2013
- Primary completion
- Nov 2019
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in phantom limb pain (PLP), sponsored by University of California, San Diego. Started Dec 2013; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
phantom limb pain (PLP)
Beyond the preview
Go deeper on NCT01824082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01824082.